BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 3408455)

  • 41. ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control.
    Haematologica; 1985; 70(3):269-70. PubMed ID: 3932161
    [No Abstract]   [Full Text] [Related]  

  • 42. Comparison of thromboplastins using the ISI and INR system.
    Moriarty HT; Lam-Po-Tang PR; Anastas N
    Pathology; 1990 Apr; 22(2):71-6. PubMed ID: 2235100
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
    Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A
    Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prothrombin time standardization report of the expert panel on oral anticoagulant control: a minority opinion.
    Miale JB
    Thromb Haemost; 1979 Dec; 42(4):1132-4. PubMed ID: 542926
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Methodological aspects of the photometric determination of prothrombin time using chromogenic substrates].
    Dati F; Kolde HJ; Heimburger N; Keller F
    J Clin Chem Clin Biochem; 1986 Nov; 24(11):877-88. PubMed ID: 3806016
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Control of anticoagulant therapy with coumarin derivatives. Evolution of the tests used and their standardization].
    Recalcati P; Perini A; Binda A
    Arch Sci Med (Torino); 1979; 136(3):369-84. PubMed ID: 398692
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Standardization of the INR: how good is your laboratory's INR and can it be improved?
    Favaloro EJ; Adcock DM
    Semin Thromb Hemost; 2008 Oct; 34(7):593-603. PubMed ID: 19085760
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of frozen plasma calibrants for enhanced standardization of the international normalized ratio (INR): a multi-center study.
    Adcock DM; Johnston M
    Thromb Haemost; 2002 Jan; 87(1):74-9. PubMed ID: 11848460
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The "therapeutic range" of the one-stage prothrombin time in the control of anticoagulant therapy: the effect of different thromboplastin preparations.
    Bailey EL; Harper TA; Pinkerton PH
    Can Med Assoc J; 1971 Nov; 105(10):1041-3 passim. PubMed ID: 5150206
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The international normalization ratio in the monitoring of oral anticoagulant therapy].
    Sansores-García L; Majluf-Cruz AS; Vargas-Vorácková F; Labardini-Méndez J
    Rev Invest Clin; 1993; 45(5):463-7. PubMed ID: 8134728
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Is the international normalized ratio (INR) indispensable in clinical practice?].
    Witt I
    Dtsch Med Wochenschr; 1994 Nov; 119(45):1529-31. PubMed ID: 7956786
    [No Abstract]   [Full Text] [Related]  

  • 52. The response of Quick's prothrombin time test to oral anticoagulation. Influence of thromboplastin source and calcium chloride concentration.
    van den Besselaar AM
    Arch Pathol Lab Med; 1994 Feb; 118(2):145-9. PubMed ID: 8311653
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Standardization of the prothrombin time: clinical results with a recombinant tissue factor reagent.
    Kolde HJ
    Haematologica; 1995; 80(2 Suppl):7-13. PubMed ID: 7628775
    [No Abstract]   [Full Text] [Related]  

  • 54. The calibration of rabbit tissue thromboplastins: experience of the Dutch Reference Laboratory for anticoagulant control.
    van den Besselaar AM; Hermans J; van der Velde EA; Bussemaker-Verduyn den Boer E; van Halem-Visser LP; Jansen-Grüter R; Loeliger EA
    J Biol Stand; 1986 Oct; 14(4):305-17. PubMed ID: 3558415
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thromboplastin related differences in the determination of international normalised ratio: a cause for concern? Steering Committee of the UK National External Quality Assessment Scheme in Blood Coagulation.
    Kitchen S; Walker ID; Woods TA; Preston FE
    Thromb Haemost; 1994 Sep; 72(3):426-9. PubMed ID: 7855795
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral anticoagulant monitoring by laboratory or near-patient testing: what a clinician should be aware of.
    Tripodi A; Breukink-Engbers WG; van den Besselaar AM
    Semin Vasc Med; 2003 Aug; 3(3):243-54. PubMed ID: 15199457
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control.
    Clin Chim Acta; 1985 Mar; 146(2-3):229H-233H. PubMed ID: 3987050
    [No Abstract]   [Full Text] [Related]  

  • 58. [Standardized prothrombin time determinations and optimal anticoagulant therapy].
    Jespersen J; Hansen MS; Dyerberg J; Ingerslev J; Jensen G; Jørgensen M; Laursen B; Nielsen JD; Svendsen TL
    Ugeskr Laeger; 1991 Jan; 153(5):355-60. PubMed ID: 1994562
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Calibration of BCT/441, the ICSH reference preparation for thromboplastin.
    Thomson JM; Darby KV; Poller L
    Thromb Haemost; 1986 Jun; 55(3):379-82. PubMed ID: 3750267
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Standardizing the prothrombin time. Calibrating coagulation instruments as well as thromboplastin.
    Becker DM; Humphries JE; Walker FB; DeMong LK; Bopp JS; Acker MN
    Arch Pathol Lab Med; 1993 Jun; 117(6):602-5. PubMed ID: 8503731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.